Bellicum pharmaceuticals, inc. reports earnings results for the third quarter ended september 30, 2019

Bellicum pharmaceuticals, inc. announced earnings results for the third quarter ended september 30, 2019. for the third quarter, the company announced total revenue was usd 103,000 compared to usd 292,000 a year ago. operating loss was usd 23.437 million compared to usd 23.228 million a year ago. net loss was usd 32.032 million compared to usd 23.801 million a year ago. basic loss per share was usd 0.68 compared to usd 0.55 a year ago. for the nine months, total revenue was usd 2.010 million compared to usd 808,000 a year ago. operating loss was usd 73.464 million compared to usd 68.899 million a year ago. net loss was usd 83.496 million compared to usd 70.816 million a year ago. basic loss per share was usd 1.82 compared to usd 1.81 a year ago.
BLCM Ratings Summary
BLCM Quant Ranking